Revelation Biosciences Warrant
REVBW
20 hedge funds and large institutions have $2.4M invested in Revelation Biosciences Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
11% more funds holding
Funds holding: 18 → 20 (+2)
34% less capital invested
Capital invested by funds: $3.63M → $2.4M (-$1.23M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCAM
Owl Creek Asset Management
New York
|
+$420K |
| 2 |
HF
HRT Financial
New York
|
+$22.8K |
| 3 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
+$18.4K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.33M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$344K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$275K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$163K |
| 5 |
Walleye Capital
New York
|
-$55.7K |
REVBW Hedge Fund Activity: Q4 2021 in Review
20 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2021, worth a combined $2.4M — down 34% from $3.63M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new REVBW positions and 6 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Owl Creek Asset Management, adding an estimated $420K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.33M sold.
- 20 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2021, up from 18 in Q3 2021.
- Funds reported $2.4M of Revelation Biosciences Warrant stock for Q4 2021, down 34% quarter-over-quarter.
- 8 funds opened new Revelation Biosciences Warrant positions in Q4 2021 and 6 closed out, a net change of +2 holders.
- The largest Revelation Biosciences Warrant buyer in Q4 2021 was Owl Creek Asset Management, an estimated $420K added.
- The largest Revelation Biosciences Warrant seller in Q4 2021 was Mangrove Partners, an estimated $1.33M sold.
Based on aggregated 13F filings for Q4 2021.